Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002056296-25-000003
Filing Date
2025-05-13
Accepted
2025-05-13 18:14:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7813
  Complete submission text file 0002056296-25-000003.txt   9439
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Subject) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91373 | Film No.: 25941937
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address PHILIPP-VON-ZABERN-PLATZ 1 MAINZ 2M D-55116
Business Address PHILIPP-VON-ZABERN-PLATZ 1 MAINZ 2M D-55116 49-6131-9084-0
Medine GmbH (Filed by) CIK: 0001803150 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SCHEDULE 13G/A